Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison of Kinesio® Taping Methods for Subjects With Patellar Tendonitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04219917
Recruitment Status : Recruiting
First Posted : January 7, 2020
Last Update Posted : February 26, 2020
Sponsor:
Information provided by (Responsible Party):
North Dakota State University

Brief Summary:

The purpose of this study is to explore the possible effects Kinesio Tape may have on proprioception in individuals with patellar tendonitis. A supportive knee application, a facilitative hip application, and a combination of the two will be applied and compared. Within and between group comparisons will be drawn.

Participants will report for two research sessions with 24-36 hours between. Prior to arrival, they will complete a digital Victorian Institute of Sport Assessment for Patellar Tendonitis (VISA-P) and email it to the researcher. Participants must score less than 80 (out of a possible 100) to be considered for this study. If the individual meets the inclusion criteria, he/she will be scheduled for the 1st session. Upon arrival to the first session, informed consent will be obtained, the VISA-P will be reviewed, and intance of patellar tendonitis will be confirmed through palpation. Participants will then completed a Tampa Scale for Kinesiophobia (TSK) to measure fear of movement and a Visual Analog Scale (VAS) to measure overall pain. Height and weight measurments will be taken due to requirements of the Biodex Balance System (BBS), which will be used for balance measurements. Participants will take two, twenty-second practice tests, one with eyes open and one with eyes closed, followed by two minutes rest. Baseline testing will then be completed as follows: the participant will complete two tests with eyes open, and two tests with eyes closed on the injured leg, each with one minute rest between. The participant will then be taped with Kinesio Tape to either the hip, knee, or both the hip and knee according to the random group assignment. They will then rest for 15 minutes and complete a second round of balance testing with the same parameters as baseline testing. Participants will be scheduled for a second day no less that 24 hours and no more than 36 hours for re-test purposes.

On the second day of testing, participants will be given $10 for their participation on Day 1. If they want to continue with testing procedures, they will participate in the same balance testing procedures as Day 1. The integrety of the tape application will be confirmed, and second TSK and VAS scale will be administered. A final round of balance testing will be completed, and the participant will receive an additional $10 if they choose to complete both days of testing.

This research will allow us to compare results of the TSK, the VAS and the BBS testing both within subject and between group.


Condition or disease Intervention/treatment Phase
Patellar Tendinitis Other: Kinesio Tape Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Comparison of Kinesio® Taping Methods for Subjects With Patellar Tendonitis
Actual Study Start Date : December 20, 2019
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020

Arm Intervention/treatment
Experimental: Hip
Gluteus medius facilitation tape
Other: Kinesio Tape
Kinesio Tape will be applied to treat the pain associated with patellar tendonitis, to treat the cause of the pain, and to treat both factors.

Experimental: Knee
Patellar sling tape
Other: Kinesio Tape
Kinesio Tape will be applied to treat the pain associated with patellar tendonitis, to treat the cause of the pain, and to treat both factors.

Experimental: Hip and Knee
Gluteus medius facilitation and patellar sling tape
Other: Kinesio Tape
Kinesio Tape will be applied to treat the pain associated with patellar tendonitis, to treat the cause of the pain, and to treat both factors.




Primary Outcome Measures :
  1. Tampa Scale for Kinesiophobia [ Time Frame: 24 hours ]
    Measures fear of movement, score range 17-68, higher score means higher degree of kinesiophobia

  2. Visual Analog Scale [ Time Frame: 24 hours ]
    Measures overall pain, score range 1-10, higher score indicates more pain

  3. Biodex Balance System [ Time Frame: 24 hours ]
    Measures balance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • score of less than 80 on the Victorian Institute of Sport Assessment for Patellar Tendonitis (VISA-P)
  • experienced patellar tendon pain for greater than 14 days
  • tender to palpation at the patellar tendon.

Exclusion Criteria:

  • knee surgery in the last six months
  • acute injury to the knee
  • any pain in the ankles, hips or core that may compromise balance testing
  • any allergy to adhesive
  • malignancies
  • cellulitis
  • skin infection
  • diabetes
  • fragile skin

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04219917


Contacts
Layout table for location contacts
Contact: Katie Lyman, PhD 701-231-8208 katie.lyman@ndsu.edu

Locations
Layout table for location information
United States, North Dakota
North Dakota State University Recruiting
Fargo, North Dakota, United States, 58102
Contact: Kristy Shirley    701-231-8995    kristy.shirley@ndsu.edu   
Sponsors and Collaborators
North Dakota State University
Layout table for additonal information
Responsible Party: North Dakota State University
ClinicalTrials.gov Identifier: NCT04219917    
Other Study ID Numbers: HE20097
First Posted: January 7, 2020    Key Record Dates
Last Update Posted: February 26, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases
Tendon Injuries
Wounds and Injuries